Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1992-8-6
|
pubmed:abstractText |
Of all known schizophrenics living in Nithsdale, south-west Scotland, 146 (88%) were examined for the presence of the three principal movement disorders secondary to antipsychotic medication, namely akathisia, tardive dyskinesia and Parkinsonism. Of these, 18% had akathisia, 5% pseudoakathisia, 29% tardive dyskinesia, 8% persistent tardive dyskinesia, and 27% Parkinsonism. No movement disorder was seen in 445, 36% had one and 20% had more than one movement disorder. Plasma neuroleptic levels at the time of clinical assessment were measured by the radioreceptor technique. Correlations between dose and plasma level were low; the ratio of mean plasma concentration to mean dose was greatest with fluphenazine decanoate and lowest for sulpiride. The concentration:dose ratio was higher in the elderly. There was no relationship between neuroleptic levels and akathisia, Parkinsonism or tardive dyskinesia. Additional psychotropic medication influenced neuroleptic levels. In 9% of patients receiving oral antipsychotic medication, no drug was detected in plasma.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0007-1250
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
160
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
793-9
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:1352165-Adult,
pubmed-meshheading:1352165-Antipsychotic Agents,
pubmed-meshheading:1352165-Cross-Sectional Studies,
pubmed-meshheading:1352165-Female,
pubmed-meshheading:1352165-Humans,
pubmed-meshheading:1352165-Male,
pubmed-meshheading:1352165-Middle Aged,
pubmed-meshheading:1352165-Movement Disorders,
pubmed-meshheading:1352165-Plasma,
pubmed-meshheading:1352165-Prevalence,
pubmed-meshheading:1352165-Psychiatric Status Rating Scales,
pubmed-meshheading:1352165-Radioligand Assay,
pubmed-meshheading:1352165-Schizophrenia,
pubmed-meshheading:1352165-Spectrometry, Fluorescence
|
pubmed:year |
1992
|
pubmed:articleTitle |
The Nithsdale schizophrenia surveys. IX: Akathisia, parkinsonism, tardive dyskinesia and plasma neuroleptic levels.
|
pubmed:affiliation |
Crichton Royal Hospital, Dumfries, Scotland.
|
pubmed:publicationType |
Journal Article
|